Apogee Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Name: Apogee Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Apogee Therapeutics Inc.
Rating: 1.20375
Author: Trendlyne DVM scores

about

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with h...

36.53 -1.90 (-4.94%)

42.47% Fall from 52W High

1.5M

XNAS Volume

High volume today

XNAS 19 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

6.5 / 100

Technically Neutral

41.7 / 100

No estimates available

Apogee Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Apogee Therapeutics Inc. Live Stock Price Today, Share Analysis and Chart

Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with h...

42.47% Fall from 52W High

High volume today

SWOT Analysis

Apogee Therapeutics Inc Live Price Chart